Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis

Background & Aims - In chronic liver diseases, inflammation induces oxidative stress and thus may contribute to the progression of liver injury, fibrosis, and carcinogenesis. The KEAP1/NRF2 axis is a major regulator of cellular redox balance. In the present study, we investigated whether the KEA...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohs, Antje (Author) , Otto, Tobias (Author) , Schneider, Kai Markus (Author) , Peltzer, Mona (Author) , Boekschoten, Mark (Author) , Holland, Christian H. (Author) , Hudert, Christian A. (Author) , Kalveram, Laura (Author) , Wiegand, Susanna (Author) , Sáez Rodríguez, Julio (Author) , Longerich, Thomas (Author) , Hengstler, Jan G. (Author) , Trautwein, Christian (Author)
Format: Article (Journal)
Language:English
Published: 2021
In: Journal of hepatology
Year: 2021, Volume: 74, Issue: 3, Pages: 638-648
ISSN:1600-0641
DOI:10.1016/j.jhep.2020.09.037
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jhep.2020.09.037
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0168827820336953
Get full text
Author Notes:Antje Mohs, Tobias Otto, Kai Markus Schneider, Mona Peltzer, Mark Boekschoten, Christian H. Holland, Christian A. Hudert, Laura Kalveram, Susanna Wiegand, Julio Saez-Rodriguez, Thomas Longerich, Jan G. Hengstler, Christian Trautwein

MARC

LEADER 00000caa a2200000 c 4500
001 175353268X
003 DE-627
005 20240413193252.0
007 cr uuu---uuuuu
008 210409s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jhep.2020.09.037  |2 doi 
035 |a (DE-627)175353268X 
035 |a (DE-599)KXP175353268X 
035 |a (OCoLC)1341403957 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Mohs, Antje  |e VerfasserIn  |0 (DE-588)1205682147  |0 (DE-627)1691305553  |4 aut 
245 1 0 |a Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis  |c Antje Mohs, Tobias Otto, Kai Markus Schneider, Mona Peltzer, Mark Boekschoten, Christian H. Holland, Christian A. Hudert, Laura Kalveram, Susanna Wiegand, Julio Saez-Rodriguez, Thomas Longerich, Jan G. Hengstler, Christian Trautwein 
246 3 0 |a two 
264 1 |c 2021 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 24 October 2020 
500 |a Gesehen am 02.09.2021 
520 |a Background & Aims - In chronic liver diseases, inflammation induces oxidative stress and thus may contribute to the progression of liver injury, fibrosis, and carcinogenesis. The KEAP1/NRF2 axis is a major regulator of cellular redox balance. In the present study, we investigated whether the KEAP1/NRF2 system is involved in liver disease progression in humans and mice. - Methods - The clinical relevance of oxidative stress was investigated by liver RNA sequencing in a well-characterized cohort of patients with non-alcoholic fatty liver disease (n = 63) and correlated with histological and clinical parameters. For functional analysis, hepatocyte-specific Nemo knockout (NEMOΔhepa) mice were crossed with hepatocyte-specific Keap1 knockout (KEAP1Δhepa) mice. - Results - Immunohistochemical analysis of human liver sections showed increased oxidative stress and high NRF2 expression in patients with chronic liver disease. RNA sequencing of liver samples in a human pediatric NAFLD cohort revealed a significant increase of NRF2 activation correlating with the grade of inflammation, but not with the grade of steatosis, which could be confirmed in a second adult NASH cohort. In mice, microarray analysis revealed that Keap1 deletion induces NRF2 target genes involved in glutathione metabolism and xenobiotic stress (e.g., Nqo1). Furthermore, deficiency of one of the most important antioxidants, glutathione (GSH), in NEMOΔhepa livers was rescued after deleting Keap1. As a consequence, NEMOΔhepa/KEAP1Δhepa livers showed reduced apoptosis compared to NEMOΔhepa livers as well as a dramatic downregulation of genes involved in cell cycle regulation and DNA replication. Consequently, NEMOΔhepa/KEAP1Δhepa compared to NEMOΔhepa livers displayed decreased fibrogenesis, lower tumor incidence, reduced tumor number, and decreased tumor size. - Conclusions - NRF2 activation in patients with non-alcoholic steatohepatitis correlates with the grade of inflammation, but not steatosis. Functional analysis in mice demonstrated that NRF2 activation in chronic liver disease is protective by ameliorating fibrogenesis, initiation and progression of hepatocellular carcinogenesis. - Lay summary - The KEAP1 (Kelch-like ECH-associated protein-1)/NRF2 (erythroid 2-related factor 2) axis has a major role in regulating cellular redox balance. Herein, we show that NRF2 activity correlates with the grade of inflammation in patients with non-alcoholic steatohepatitis. Functional studies in mice actually show that NRF2 activation, resulting from KEAP1 deletion, protects against fibrosis and cancer. 
650 4 |a Chronic liver disease 
650 4 |a KEAP1 
650 4 |a NASH 
650 4 |a NRF2 
650 4 |a oxidative stress 
700 1 |a Otto, Tobias  |e VerfasserIn  |4 aut 
700 1 |a Schneider, Kai Markus  |e VerfasserIn  |4 aut 
700 1 |a Peltzer, Mona  |e VerfasserIn  |4 aut 
700 1 |a Boekschoten, Mark  |e VerfasserIn  |4 aut 
700 1 |a Holland, Christian H.  |d 1991-  |e VerfasserIn  |0 (DE-588)1203164831  |0 (DE-627)1687980101  |4 aut 
700 1 |a Hudert, Christian A.  |e VerfasserIn  |4 aut 
700 1 |a Kalveram, Laura  |e VerfasserIn  |4 aut 
700 1 |a Wiegand, Susanna  |e VerfasserIn  |4 aut 
700 1 |a Sáez Rodríguez, Julio  |d 1978-  |e VerfasserIn  |0 (DE-588)133764362  |0 (DE-627)555766632  |0 (DE-576)300083114  |4 aut 
700 1 |a Longerich, Thomas  |d 1974-  |e VerfasserIn  |0 (DE-588)128494514  |0 (DE-627)373916124  |0 (DE-576)297178059  |4 aut 
700 1 |a Hengstler, Jan G.  |e VerfasserIn  |4 aut 
700 1 |a Trautwein, Christian  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of hepatology  |d Amsterdam [u.a.] : Elsevier Science, 1985  |g 74(2021), 3, Seite 638-648  |h Online-Ressource  |w (DE-627)320984486  |w (DE-600)2027112-8  |w (DE-576)093888856  |x 1600-0641  |7 nnas  |a Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis 
773 1 8 |g volume:74  |g year:2021  |g number:3  |g pages:638-648  |g extent:11  |a Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis 
856 4 0 |u https://doi.org/10.1016/j.jhep.2020.09.037  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0168827820336953  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210409 
993 |a Article 
994 |a 2021 
998 |g 128494514  |a Longerich, Thomas  |m 128494514:Longerich, Thomas  |d 910000  |d 912000  |e 910000PL128494514  |e 912000PL128494514  |k 0/910000/  |k 1/910000/912000/  |p 11 
998 |g 133764362  |a Sáez Rodríguez, Julio  |m 133764362:Sáez Rodríguez, Julio  |d 910000  |d 912900  |e 910000PS133764362  |e 912900PS133764362  |k 0/910000/  |k 1/910000/912900/  |p 10 
998 |g 1203164831  |a Holland, Christian H.  |m 1203164831:Holland, Christian H.  |d 140000  |e 140000PH1203164831  |k 0/140000/  |p 6 
999 |a KXP-PPN175353268X  |e 3904224905 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"title":[{"subtitle":"official journal of the European Association for the Study of the Liver","title_sort":"Journal of hepatology","title":"Journal of hepatology"}],"note":["Gesehen am 18.02.2020"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisher":"Elsevier Science ; Wiley-Blackwell","dateIssuedKey":"1985","dateIssuedDisp":"1985-","publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]"}],"pubHistory":["1.1985 -"],"id":{"zdb":["2027112-8"],"issn":["1600-0641"],"eki":["320984486"]},"disp":"Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitisJournal of hepatology","part":{"pages":"638-648","volume":"74","year":"2021","extent":"11","text":"74(2021), 3, Seite 638-648","issue":"3"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"320984486"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Available online 24 October 2020","Gesehen am 02.09.2021"],"language":["eng"],"physDesc":[{"extent":"11 S."}],"recId":"175353268X","id":{"doi":["10.1016/j.jhep.2020.09.037"],"eki":["175353268X"]},"name":{"displayForm":["Antje Mohs, Tobias Otto, Kai Markus Schneider, Mona Peltzer, Mark Boekschoten, Christian H. Holland, Christian A. Hudert, Laura Kalveram, Susanna Wiegand, Julio Saez-Rodriguez, Thomas Longerich, Jan G. Hengstler, Christian Trautwein"]},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"2021"}],"title":[{"title_sort":"Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis","title":"Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis"}],"person":[{"role":"aut","display":"Mohs, Antje","family":"Mohs","given":"Antje"},{"family":"Otto","display":"Otto, Tobias","role":"aut","given":"Tobias"},{"role":"aut","display":"Schneider, Kai Markus","family":"Schneider","given":"Kai Markus"},{"display":"Peltzer, Mona","role":"aut","family":"Peltzer","given":"Mona"},{"given":"Mark","family":"Boekschoten","role":"aut","display":"Boekschoten, Mark"},{"display":"Holland, Christian H.","role":"aut","family":"Holland","given":"Christian H."},{"display":"Hudert, Christian A.","role":"aut","family":"Hudert","given":"Christian A."},{"family":"Kalveram","display":"Kalveram, Laura","role":"aut","given":"Laura"},{"role":"aut","display":"Wiegand, Susanna","family":"Wiegand","given":"Susanna"},{"family":"Sáez Rodríguez","display":"Sáez Rodríguez, Julio","role":"aut","given":"Julio"},{"given":"Thomas","family":"Longerich","role":"aut","display":"Longerich, Thomas"},{"given":"Jan G.","role":"aut","display":"Hengstler, Jan G.","family":"Hengstler"},{"given":"Christian","family":"Trautwein","role":"aut","display":"Trautwein, Christian"}]} 
SRT |a MOHSANTJEOHEPATOCYTE2021